We serve Chemical Name:2-Bromo-4-methoxy-6-nitroaniline CAS:10172-35-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-4-methoxy-6-nitroaniline
CAS.NO:10172-35-7
Synonyms:4-Amino-3-brom-5-nitro-anisol;Benzenamine, 2-bromo-4-methoxy-6-nitro-;2-Bromo-4-methoxy-6-nitroaniline
Molecular Formula:C7H7BrN2O3
Molecular Weight:247.046
HS Code:2922299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.1±37.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.634
PSA:81.07000
Exact Mass:245.964005
LogP:3.12
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Amino-3-brom-5-nitro-anisol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-4-methoxy-6-nitroaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Amino-3-brom-5-nitro-anisol Use and application,2-Bromo-4-methoxy-6-nitroaniline technical grade,usp/ep/jp grade.
Related News: In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. 2-Bromo-4-methoxy-6-nitroaniline manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Bromo-4-methoxy-6-nitroaniline supplier In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. 2-Bromo-4-methoxy-6-nitroaniline vendor While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. 2-Bromo-4-methoxy-6-nitroaniline factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.
